Login / Signup
He Feng
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Clinical Trial
Low Density Lipoprotein
Open Label
Cardiovascular Risk Factors
Top Venues
Journal of diabetes research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Zhaohu Hao
,
Huang Xiao
,
Shao Hailin
,
He Feng
Efficacy and Safety of Dapagliflozin versus Liraglutide in Patients with Overweight or Obesity and Type 2 Diabetes Mellitus: A Randomised Controlled Clinical Trial in Tianjin, China.
Journal of diabetes research
2022 (2022)